Back

Clinical predictors of residual pulmonary hypertension at 1-year follow-up after pulmonary embolism treated by catheter-directed therapies, a sub-analysis of the USAT IH-PE registry

11 May 2026 (10:30 - 11:15)
Organised by: Logo
Congress Presentation Part of: Beyond pressure: advances in risk management for pulmonary hypertension and embolism Pulmonary Embolism (PE) HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Maurizio Bertaina

Torino North Emergency San Giovanni Bosco, Turin (Italy)

6 More presentations in this session

Presentation thumbnail
Prognostic dissociation between right atrial and right ventricular metrics in treated pulmonary hypertension
Doctor C. Kocx (Sydney, AU)
Abstract Slides
Presentation thumbnail
Improvement of size, shape but not RV function with sotatercept in pulmonary arterial hypertension: insights from a french nationwide real-world echocardiographic study
Doctor M. EL BLIDI (Le Kremlin-Bicetre, FR)
Abstract Slides
Presentation thumbnail
Beyond clinical risk scores in pulmonary arterial hypertension: does invasive hemodynamic assessment provide additional value?
Doctor A. Henriques Silva (Almada, PT)
Abstract Slides
Presentation thumbnail
Beta-blockers use in patients with post-capillary pulmonary hypertension: insights from the multicentre prospective PH-HF study
Doctor C. Fauvel (Rouen, FR)
Abstract Slides
Presentation thumbnail
Persistent hyponatraemia as a predictor of in-hospital mortality in acute pulmonary embolism
Doctor J. Gouveia Fiuza (Viseu, PT)
Abstract Slides

Access the full session

Session thumbnail
Beyond pressure: advances in risk management for pulmonary hypertension and embolism

The Event

Event poster

Heart Failure 2026

11 May 2026 10:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources